Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta)

NeuroReport

Volumn 8, Issue 17, 1997, Pages 3833-3836

  Koutsilieri, Eleni ^a   Götz, Mario E ^a   Sopper, Sieghart ^b   Stahl Hennig, Christiane ^c   Czub, Markus ^b   Ter Meulen, Volker ^b   Riederer, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

Author keywords

CSF; Dopamine; Monkeys; Serotonin; SIV

Indexed keywords

MONOAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; INFECTION RISK; MACROPHAGE ACTIVATION; MONKEY; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0031438053     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712010-00034     Document Type: Article

References (21)

1. Navia BA, Jordan BD and Price RW. Ann Neurol 19, 517-524 (1986).
2. Berger JR, Kumar M, Kumar A et al. AIDS 8, 67-71 (1994).
3. Navia BA, Jordan BD and Price RW. Ann Neurol 19, 525-535 (1986).
4. Sardar AM, Czudek C and Reynolds GP. NeuroReport 7, 910-912 (1996).
5. Essex M and Kanki PJ. Sci Am 259, 64-71 (1988).
6. Persidsky Y, Nottet HSLM, Sasseville VG et al. J Neurovirol 1, 229-243 (1995).
7. Stahl-Hennig C, Voss G, Dittmer U et al. AIDS 7, 787-795 (1993).
8. Wagner J, Vitali MG, Palfreyman MH et al. J Neurochem 38, 1241-1254 (1982).
9. Higley JD, Suomi SJ and Linnoila M. Psychopharmacology 103, 551-556 (1991).
10. Kraemer GW and McKinney WT. Psychopharmacology 86, 182-189 (1985).
11. Goldman-Rakic PS, Brown PS and Brown RM. Neuroscience 6, 177-187 (1981).
12. Bacopoulos NG, Redmond DE and Roth RH. J Neurochem 32, 1215-1218 (1979).
13. Clarke AS, Hedeker DR, Ebert MH et al. Biol Psychiatry 40, 338-352 (1996).
14. Britton CB, Cote L and Alstiel L. Neurology 39 (suppl), 380 (1989).
15. Larsson M, Hagberg L, Forsman A et al. VII International Conference on AIDS. Florence (abstract MB2018) (1991).
16. Candito M, Durant J, Gurle V et al. AIDS 9, 1100-1101 (1995).
17. Sofic E, Riederer P, Schmidt B et al. Biogenic Amines 8, 293-298 (1992).
18. Reynolds GP and Sardar AM. AIDS 10, 1303-1204 (1996).
19. Higley JD, Suomi SJ and Linnoila M. Am J Primatol 14, 425 (1988).
20. Rottenberg DA, Moeller JR, Strother SC et al. Ann Neurol 22, 700-706 (1987).
21. Van Gorp WG, Mandelkern MA, Gee M et al. J Neuropsychiatry Clin Neurosci 4, 280-287 (1992).